Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview - Natural Product Reports (RSC Publishing) DOI:10.1039/C4NP00080C
ONIVYDE (liposomal irinotecan) for Pancreatic Cancer - Cancer Therapy Advisor
Cellular irinotecan resistance in colorectal cancer and overcoming irinotecan refractoriness through various combination trials including DNA methyltransferase inhibitors: a review
Drug resistance and new therapies in colorectal cancer
Frontiers | Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy | Cellular and Infection Microbiology
Transport pathway of irinotecan. Notes: A prodrug, irinotecan, is moved... | Download Scientific Diagram
IJMS | Free Full-Text | Irinotecan—Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview | HTML
TOPOISOMERASE INHIBITORS - Pocket Oncology (Pocket Notebook Series), 1st Ed.
IJMS | Free Full-Text | Irinotecan—Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview | HTML
Combination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1 - Liu - 2021 - Advanced Science - Wiley Online Library
Oncology
SN-38 - an overview | ScienceDirect Topics
Oxaliplatin: pre-clinical perspectives on the mechanisms of action, response and resistance - ecancer
5-Fluorouracil: mechanisms of action and clinical strategies | Nature Reviews Cancer
Molecules | Free Full-Text | Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment | HTML
Irinotecan - FDA prescribing information, side effects and uses
Irinotecan pathway. Irinotecan is a prodrug that, after administration,... | Download Scientific Diagram
Cytotoxic drugs Antineoplastic agents - ppt download
Metabolism and mechanism of action of Irinotecan (CPT-11). The... | Download Scientific Diagram
Oncology
Irinotecan - Wikipedia
Lipid-based nanoformulation of irinotecan: dual mechanism of action allows for combination chemo/angiogenic therapy | Nanomedicine
Pharmacological inhibition of bacterial β-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo - ScienceDirect
